Biospecimen Procurement Market Analysis, Demand and Growth Rate Forecast 2034
According to market projections, the biospecimen procurement market sector is expected to grow from USD 85.94 million in 2024 to USD 191.1 million by 2034, reflecting a CAGR of 8.60%. Biospecimen procurement is increasing due to the increased need for high-quality biospecimens in various life science R&D. Similarly, the demand for human biospecimens is rising due to their requirement at all stages of product development, from basic research to the verification and validation of studies. The rising study of genomics and proteomics in North America is promoting the growth of the region.
Last Updated : 23 December 2025Category: BiotechnologyInsight Code: 5573Format: PDF / PPT / Excel
Importance of Biospecimen Procurement in Biomedical Research
Market Definition and Scope
Research Methodology
Assumptions and Limitations
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Regulatory Landscape
Impact of Technological Advancements
Trends Shaping the Biospecimen Procurement Industry
Impact of COVID-19 on Biospecimen Collection and Supply
Market Segmentations
By Type
Oncological Studies
Tissue-Based Biospecimens
Formalin-Fixed Paraffin-Embedded (FFPE)
Frozen Tissue
Blood-Based Biospecimens
Whole Blood
Plasma / Serum
Other Biospecimens
Non-Oncological Studies
Tissue-Based Biospecimens
Formalin-Fixed Paraffin-Embedded (FFPE)
Frozen Tissue
Blood-Based Biospecimens
Whole Blood
Plasma / Serum
Other Biospecimens
By Region
North America
U.S.
Biobank Networks and Federal Initiatives
Dominance in Precision Medicine Research
Canada
National Biobanking Programs and Institutional Collaborations
Asia Pacific
China
Expansion of Clinical Trials and Government Funding
Japan
Leading Biorepositories and Focus on Genomic Research
India
Growing Biotech Sector and International Collaborations
South Korea
Integration of AI and Biobanking Technologies
Thailand
Public-Private Partnerships and Regional Growth
Europe
Germany
Advanced Biobanking Infrastructure and Cancer Research Programs
UK
Role of NHS and UK Biobank
France
Public Research Investments and Clinical Sample Access
Italy
Growth in Translational Research and Biosample Collection
Spain
National Health System’s Support for Research
Sweden
Leadership in Longitudinal Population Cohorts
Denmark
Strong Ethical Frameworks and Data Integration
Norway
Integration of Healthcare and Research Systems
Latin America
Brazil
Expanding Pharmaceutical Industry and Genomic Projects
Mexico
Biorepository Development and Research Initiatives
Argentina
Academic Research and Government Support
Middle East and Africa (MEA)
South Africa
Pioneering Efforts in Infectious Disease Research
UAE
Investment in Health Research Infrastructure
Saudi Arabia
Genomic Medicine and National Biobanking Initiatives
Kuwait
Emerging Market and Focus on Rare Disease Research
Go-to-Market Strategy
Regional market entry approach
Partnering and distribution models
Regulatory & Compliance Landscape
Global and regional regulatory frameworks
Ethical, consent, and compliance requirements
Cross-Border Procurement & Logistics
International sourcing and movement of biospecimens
Supply chain and cold-chain considerations
Production & Supply Capacity
Global biospecimen availability and processing capacity
Regional supply dynamics
Technology Enablement
Digitalization and automation in biospecimen procurement
Data tracking and quality management systems
Government Policy & Public Infrastructure
Role of national biobanks and public funding
Policy impact on market expansion
Investment & M&A Landscape
Funding trends in biospecimen procurement
Consolidation and strategic acquisitions
Market Demand & Consumption Trends
Use across clinical trials and research
Regional demand patterns
Business Models & Partnerships
Procurement and access models
Ecosystem collaboration among hospitals, CROs, and biobanks
Opportunities & Future Outlook
Key market gaps and growth opportunities
Evolution of the market toward 2034
FAQ's
Answer : The biospecimen procurement market was valued at USD 85.94 million in 2024, reached USD 90,89 million in 2025, and is projected to grow to USD 191.1 million by 2034 at a CAGR of 8.60%.
Answer : Rising chronic disease is the factor that is driving the biospecimen procurement market.
Answer : Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.
Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare
market research. As a content reviewer, Aditi ensures the quality and accuracy of all market
insights and data presented by the research team.
Download Sample
Order Now
USA : +1 8044 419344
sales@towardshealthcare.com